• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Iridex Corp (NQ: IRIX )

    1.890 +0.480 (+34.04%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 314,244
    Open 1.550
    Bid (Size) 1.850 (1)
    Ask (Size) 1.890 (15)
    Prev. Close 1.410
    Today's Range 1.550 - 1.940
    52wk Range 1.272 - 3.650
    Shares Outstanding 16,007,161
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Iridex Reports Third Quarter 2024 Financial Results
    From IRIDEX Corporation
    Via GlobeNewswire
    Earnings Scheduled For November 12, 2024
    Via Benzinga

    Performance

    YTD
    -34.15%
    -34.15%
    1 Month
    +19.62%
    +19.62%
    3 Month
    N/A
    N/A
    6 Month
    -28.68%
    -28.68%
    1 Year
    -0.53%
    -0.53%

    More News

    Read More
    Insights into Iridex's Upcoming Earnings
    Via Benzinga
    Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex Appoints Patrick Mercer as Chief Executive Officer
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex: Q4 Earnings Insights
    Via Benzinga
    Iridex's Earnings Outlook
    Via Benzinga
    IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    Iridex Reports Second Quarter 2024 Financial Results
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex Announces Convertible Note Financing
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024
    From IRIDEX Corporation
    Via GlobeNewswire
    IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Iridex Reports First Quarter 2024 Financial Results
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex to Report First Quarter 2024 Financial Results on May 14, 2024
    From IRIDEX Corporation
    Via GlobeNewswire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    IRIX Stock Earnings: Iridex Misses EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
    From IRIDEX Corporation
    Via GlobeNewswire
    Earnings Scheduled For March 26, 2024
    Via Benzinga
    Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex Corporation Receives European Patent on MicroPulse Technology
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma
    From IRIDEX Corporation
    Via GlobeNewswire
    Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation
    From IRIDEX Corporation
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.